VAXFORM

vaxform-logo

VaxForm offers vaccine product consultation and contract development services. The company was founded in 2010 and is headquartered in Lehigh Valley, Pennsylvania.

#SimilarOrganizations #People #Financial #Website #More

VAXFORM

Social Links:

Industry:
Biotechnology Health Care Medical Pharmaceutical

Founded:
2010-01-01

Address:
Lehigh Valley, Pennsylvania, United States

Country:
United States

Website Url:
http://www.vaxform.com

Total Employee:
1+

Status:
Active

Email Addresses:
[email protected]

Total Funding:
481 K USD

Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro Apple Mobile Web Clips Icon COVID-19 GoDaddy CDN GoDaddy Website Builder


Similar Organizations

biogenes-logo

Biogenes

BioGenes offers custom antibody and immunoassay development and services.

biointervene-logo

BioIntervene

BioIntervene is engages in drug discovery and development.

bionpharma-logo

BionPharma

BionPharma develops and commercializes affordable quality generics and builds strong and effective partnerships.

nuchem-sciences-logo

NuChem Sciences

NuChem Sciences is a drug discovery in chemistry contract research organization (CRO) located in Montréal and Lévis.

salix-pharmaceuticals-logo

Salix Pharmaceuticals

Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.

solid-form-solutions-logo

Solid Form Solutions

Solid Form Solutions, a provider of solid state chemistry and crystallization development services

teconomy-partners-logo

TEConomy Partners

TEConomy Partners produces innovation-based economic development strategies.

Current Employees Featured

garry-morefield_image

Garry Morefield
Garry Morefield President and Founder @ VaxForm
President and Founder
2010-09-01

Founder


garry-morefield_image

Garry Morefield

Investors List

national-science-foundation_image

National Science Foundation

National Science Foundation investment in Grant - VaxForm

national-science-foundation_image

National Science Foundation

National Science Foundation investment in Grant - VaxForm

Official Site Inspections

http://www.vaxform.com

  • Host name: a16e665f42988324c.awsglobalaccelerator.com
  • IP address: 76.223.105.230
  • Location: Seattle United States
  • Latitude: 47.54
  • Longitude: -122.3032
  • Metro Code: 819
  • Timezone: America/Los_Angeles
  • Postal: 98108

Loading ...

More informations about "VaxForm"

VaxForm - Crunchbase Company Profile & Funding

VaxForm offers vaccine product consultation and contract development services. The company was founded in 2010 and is headquartered in Lehigh Valley, Pennsylvania.See details»

VaxForm - LinkedIn

VaxForm envisions a world where formulation takes a leading role in providing solutions to the development of vaccines | VaxForm specializes in the development of vaccine formulations.See details»

VaxForm Company Profile 2024: Valuation, Funding & Investors

Information on valuation, funding, cap tables, investors, and executives for VaxForm. Use the PitchBook Platform to explore the full profile.See details»

Vaxform LLC - Company Profile and News - Bloomberg Markets

Vaxform, LLC was founded in 2010. The company's line of business includes the production of bacterial and virus vaccines, toxoids, and analogous products.See details»

Vaxform, LLC Company Profile | Bethlehem, PA - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for Vaxform, LLC of Bethlehem, PA. Get the latest business insights from Dun & Bradstreet.See details»

USSF and Vaxform Developing Oral COVID-19 Vaccine

Dec 3, 2020 · Governor Tom Wolf announced that US Specialty Formulations LLC (USSF), a pharmaceutical manufacturing company, will expand its operations in Allentown, Lehigh …See details»

OraSure's Dr. Stephen Tang & VaxForm's Dr. Garry Morefield - WDIY

Feb 5, 2021 · Rayna welcomes Dr. Stephen Tang, President and CEO of OraSure Technologies, to talk about his company's COVID-19 oral tests, and also speaks with Dr. Garry Morefield, …See details»

A COVID-19 vaccine that you drink? That’s what a company …

Dec 3, 2020 · USSF and VaxForm LLC, a vaccine consulting firm headed by Morefield, have been partnering on the vaccine since earlier this year, a formulation that produced antibodies in …See details»

Formulation Attributes Impact Immune Profile of an Oral and ...

Sep 24, 2024 · VaxForm has developed an oral vaccine delivery platform that elicits mucosal and systemic immune responses by targeting immune cells in the gut through C-type lectin …See details»

USSF Oral Covid-19 Vaccine Cleared for Phase One Clinical Trials

May 26, 2021 · BFTP clients US Specialty Formulations (USSF), a cGMP pharmaceutical manufacturer, and VaxForm, a vaccine development company, announced positive results …See details»

Lehigh Valley companies working on oral COVID-19 vaccines that …

Dec 3, 2020 · VaxForm has been working on oral vaccine technology since 2017. When COVID-19 broke out, the company moved its focus from other targets to SARS-CoV-2, said Dr. Garry …See details»

Company expands Allentown facility as it works on COVID-19 …

Dec 3, 2020 · USSF and its partner VaxForm are expected to request FDA approval for a COVID-19 oral and injectible vaccine in mid-2021. In order to meet that deadline, the company will …See details»

VaxForm on LinkedIn: Elodie Burlet will be there, giving a talk …

VaxForm is committed to develop next-generation vaccines that induce mucosal and protective immunity, allow self-administration, and can be stored at room temperature to facilitate global...See details»

Advancing Past Early Trials – Plus Shooting for Lifelong Immunity …

Nov 30, 2023 · Intranasal vaccines by Codagenix and Castlevax are headed into Project Next-Gen-supported phase 2b trials next year. The oral protein subunit vaccine developed by USSF …See details»

Allentown pharmaceutical firm expanding to help create COVID …

Dec 3, 2020 · An Allentown pharmaceutical manufacturing company, U.S. Specialty Formulations, is expanding again to continue its work developing a COVID-19 vaccine in partnership with …See details»

Group A Streptococcus Vaccine Targeting the Erythrogenic Toxins …

Sep 20, 2023 · VaxForm has developed a non-M-protein vaccine candidate comprised of a recombinant, genetically inactivated fusion protein that includes full-length streptococcal …See details»

Next Generation Covid Vaccines Update (No 9): Major New Hat in …

Jul 31, 2023 · It’s an intranasal booster vaccine, that’s showing signs of providing mucosal immunity in a phase 1 trial – and the university has formed a company to help develop it. …See details»

Diverse vaccine platforms safeguarding against SARS-CoV-2 and …

Jan 11, 2022 · We describe SARS-Cov-2 variants, their impact on the population, COVID-19 vaccines, diverse vaccine platforms, doses of vaccines, the efficacy of vaccines against SARS …See details»

Tracking the COVID-19 vaccines: The global landscape

Mar 30, 2023 · Both the conventional and advanced vaccine platforms are available now to develop vaccines against COVID-19. Therefore, the present systematic review focuses on the …See details»

VaxForm - Company Profile - Tracxn

3 days ago · VaxForm - Contract development & consultancy services in vaccine formulations. Raised funding over 3 rounds from 3 investors. Founded by Garry Morefield in the year 2010. …See details»

linkstock.net © 2022. All rights reserved